Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Muhammad Aamir Latif
With
Nishtar Medical University
Despite the established roles of both magnesium sulfate and terbutaline in the management of severe asthma exacerbations, there is limited comparative data on their efficacy and safety in the pediatric population. Understanding the relative benefits and risks of these therapies is crucial for optimizing treatment strategies and improving patient outcomes.
Age
5–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Known cases of asthma
Minimum duration of asthma as 6 months
Presenting with acute exacerbation of asthma
Requiring emergency treatment.
You may not be if
Children having chronic respiratory diseases (cystic fibrosis, bronchopuonary dysplasia)
Children with cardiac diseases
Children who were hospitalized in the past 2-weeks due to any reasons
Children using oral or intravenous corticosteroids or other systemic medications
Children who were unable to undergo PEFR measurements due to any reasons
Clareo Health | Randomized Controlled Trial of Intravenous Magnesium Sulfate Versus Terbutaline for Children in the Management of Acute Exacerbation of Asthma
